To determine the potential use of GAL(1-15) as an SSRI antidepressant augmentation agent, and once the interaction between GAL(1-15) and FLX was determined, the effects of this pharmacological combination were tested in an animal model of inducible depression, the bulbectomised (OBX) rat. The gene discussed is GAL; the disease is depressive symptom measurement.